GLL398
GLL398 is a potent, orally bioavailable selective estrogen receptor degrader (SERD) with an IC50 value of 1.14 nM. GLL398 shows a strong dose-dependent binding to ER with a mutation at Y537S (IC50=29.5 nM) . GLL398 blocks tumor growth in xenograft models of breast cancer.
Product Specifications
CAS Number
2077980-80-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gll398.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
OC(/C=C/C(C=C1)=CC=C1/C(C2=CC=C(B(O)O)C=C2)=C(C3=CC=CC=C3)/CC)=O
Molecular Formula
C25H23BO4
Molecular Weight
398.26
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Guo S, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180 (2) :359-368.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SR318231 1 Kit
LOC391322 Human siRNA Oligo Duplex (Locus ID 391322)
Sign In for Pricing
View Details 
QP8106-ec-500ug 500ug
Recombinant Human Programmed cell death protein 2-like Protein, GST, E.coli-500ug
Sign In for Pricing
View Details 
135170-Biotin 100 µL
USP33 (Ubiquitin-specific-processing Protease 33, Ubiquitin Carboxyl-terminal Hydrolase 33, Deubiquitinating Enzyme 33, Ubiquitin Thioesterase 33, VHL-interacting Deubiquitinating Enzyme 1, VDU1, hVDU1, KIAA1097) (Biotin)
Sign In for Pricing
View Details